Table 2.
Clinical course and outcomes of patients with COVID-19 admitted to the intensive care unit (ICU) in Chongqing, China (from January 21 to March 15, 2020).
| Clinical course and outcomes | Value | |
| Duration from initial symptom(s) to…a (days), median (IQR) | ||
| Diagnosis confirmed by PCRb test | 5 (2-7) | |
| Hospital admission | 7 (4-8) | |
| Acute respiratory distress syndrome | 7 (6-10) | |
| ICU admission | 8 (6-11) | |
| Ventilation | 10 (7-14) | |
| Cessation of viral sheddingc | 20 (16-26) | |
| Deathd | 16 (15-28) | |
| Length of ICU stay | 13 (9-19) | |
| Length of hospital stay | 22 (16-34) | |
| Outcomes (n=75), n (%) | ||
| 28-day mortalityd | 4 (5.3) | |
| 28-day mechanical ventilation dependency | 1 (1.3) | |
| Location of death (n=6), n (%) | ||
| ICU | 4 (66.7) | |
| Emergency department | 2 (33.3) | |
aTwo patients without any symptoms until hospital admission were excluded from statistical analysis.
bPCR: polymerase chain reaction.
cTwo consecutive negative nasal swab PCR tests performed at an interval of least 24 hours).
dFour patients who died in the ICU were included.